Product Information
VENLAFAXINE HCL ER 150 MG TAB is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.2333 per EA under NDC 70710135003. Its NADAC has been published 191 times since Dec 28, 2022.
FDA first approved this application on Aug 30, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710135003
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215622FDA Approved
8/30/2022
TE Code
AB
On Market Since
9/1/2022
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL ER 150 MG TAB has been published 191 times since Dec 28, 2022, and over the history we have for it it has declined 81.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2333 per EA |
|---|---|
| All-time high | $1.2452 (Feb 15, 2023) |
| All-time low | $0.1711 (May 22, 2024) |
| 52-week high | $0.3110 |
| 52-week low | $0.2085 |
| Median price | $0.2334 |
| Average price | $0.2851 |
| Largest weekly change | +83.6% (Jun 19, 2024) |
| Weeks tracked | 191 |
| Tracking since | Dec 28, 2022 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL ER 150 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL ER 150 MG TAB, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.2333 per EA (NDC 70710135003), effective Aug 19, 2026.
How has the price of VENLAFAXINE HCL ER 150 MG TAB changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL ER 150 MG TAB has declined 81.3%. It has been tracked across 191 weekly CMS publications since Dec 28, 2022.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL ER 150 MG TAB?
Since Dec 28, 2022, the NADAC for VENLAFAXINE HCL ER 150 MG TAB has ranged from a low of $0.1711 (May 22, 2024) to a high of $1.2452 (Feb 15, 2023), with a median of $0.2334 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL ER 150 MG TAB?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VENLAFAXINE HCL ER 150 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures VENLAFAXINE HCL ER 150 MG TAB?
VENLAFAXINE HCL ER 150 MG TAB (NDC 70710135003) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.